Répertoire du corps professoral

Role of megakaryocytes in Systemic Lupus Erythematosus
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2023 au 31 mars 2028

Role of phosphatidylserine-specific phospholipase A1 (PLA1A) in the pathogenesis of rheumatic diseases
Programme: Subvention stratégique de fonctionnement
Organisme(s) subventionnaire(s): Société de l'arthrite du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 janvier 2023 au 31 décembre 2025

Risk stratification and personalized therapy in lupus pregnancies
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université McGill
Du 1 octobre 2022 au 30 septembre 2027

FcgRI as a potential therapeutic target in inflammatory arthritis
Programme: Subvention stratégique de fonctionnement
Organisme(s) subventionnaire(s): Société de l'arthrite du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 janvier 2022 au 31 mars 2025

Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2020 au 31 mars 2025

Canada research chair in Innovate Systemic Autoimmune Rheumatic Disease
Programme: Chaires de recherche du Canada - Fonctionnement
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 juillet 2019 au 30 juin 2026

Financements des 2 dernières années

Megakaryocyte: a new player in systemic lupus erythematosus
Programme: Catalyst Grant Program
Organisme(s) subventionnaire(s): Lupus Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 septembre 2022 au 31 août 2023

Booster dose of mRNA SARS-CoV-2 vaccine vs non mRNA vaccine for people living with systemic autoimmune rhumatic diseases without adequate humoral response post standard mRNA vaccination
Programme: Subvention de fonctionnement:Nouveaux besoins prioritaires en recherche sur la COVID-19
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 décembre 2021 au 30 novembre 2022

Safety immUnogenicity of Covid-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED)
Organisme(s) subventionnaire(s): Agence de la santé publique du Canada
Type de financement: Subvention
Établissement tête: Université McGill
Du 1 avril 2021 au 30 septembre 2023

COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune Diseases / La réponse immunitaire au vaccin contre la COVID-19 chez des patients immunosupprimés en raison de maladies auto-immunes
Organisme(s) subventionnaire(s): Ministère de la Santé et des Services sociaux
Type de financement: Subvention
Établissement tête: Université McGill
Du 16 mars 2021 au 31 mars 2023

Maladies Rhumatismales Autoimmunes Systémiques (MRAS)
Organisme(s) subventionnaire(s): Fondation du CHU de Québec
Type de financement: Subvention
Établissement tête: Université Laval
Du 15 décembre 2020 au 31 mars 2023

The impact of antimalarial drugs in arthritis patients exposed to SARS-CoV-2- the CoVIRAL project
Organisme(s) subventionnaire(s): Société de l'arthrite du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 avril 2020 au 31 mars 2023

Understanding the pathogenesis of COVID-19
Programme: Subvention de fonctionnement : Possibilité de financement canadienne pour une intervention de recherche rapide contre la maladie à coronavirus 2019 (COVID-19)
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada, Secrétariat Inter-Conseils (Canada) (CRSH, CRSNG, IRSC)
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 mars 2020 au 28 février 2023

Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis
Organisme(s) subventionnaire(s): Société de l'arthrite du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 janvier 2020 au 31 décembre 2022

Hydroxychloroquine in systemic lupus
Programme: Subvention Projet
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université McGill
Du 1 avril 2018 au 31 mars 2023

Role of autotaxin bound to platelet-derived microparticles to development of vascular damage in arthritis.
Programme: Subvention de fonctionnement
Organisme(s) subventionnaire(s): Instituts de recherche en santé du Canada
Type de financement: Subvention
Établissement tête: Université Laval
Du 1 juillet 2015 au 31 mars 2023

Sandrine Huot, Doctorat en médecine moléculaire

Yaneisy-Nynoska Tremblay, Maîtrise en microbiologie-immunologie - avec mémoire

Encadrements terminés dans les 5 dernières années

Alix St-Aubin, Maîtrise en sciences cliniques et biomédicales - avec mémoire

Laurence Mainville, Maîtrise en épidémiologie - épidémiologie clinique - avec mémoire

Publications des 5 dernières années

Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study Vaccines, 2024/09/17. Carol A Hitchon, Dawn M. E. Bowdish, Gilles Boire, Paul R. Fortin, Louis Flamand, Vinod Chandran, Roya M. Dayam, Anne-Claude Gingras, Catherine M. Card, Inés Colmegna, Maggie J. Larché, Gilaad G. Kaplan, Luck Lukusa, Jennifer L.F. Lee, Sasha Bernatsky. DOI 10.3390/vaccines12091061

Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study ACR Open Rheumatology, 2024/09. Rami Habib, Roya M. Dayam, Carol Hitchon, Vinod Chandran, Paul R. Fortin, Gilles Boire, Dawn M. E. Bowdish, Anne‐Claude Gingras, Louis Flamand, Maggie J. Larché, Ines Colmegna, Luck Lukusa, Jennifer L. F. Lee, Daniel Pereira, Charles N. Bernstein, Nadine Lalonde, Elizabeth Turnbull, Sasha Bernatsky. DOI 10.1002/acr2.11697

Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study Advances in Rheumatology, 2024/08/06. Wen Qi, Antoine Robert, Narcisse Singbo, Lucie Ratelle, Paul R. Fortin, Louis Bessette, Jacques P. Brown, Laëtitia Michou. DOI 10.1186/s42358-024-00396-6

When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study The Journal of Rheumatology, 2024/07. Dawn M.E. Bowdish, Vinod Chandran, Carol A. Hitchon, Gilaad G. Kaplan, J. Antonio Avina-Zubieta, Paul R. Fortin, Maggie J. Larché, Gilles Boire, Anne-Claude Gingras, Roya M. Dayam, Ines Colmegna, Luck Lukusa, Jennifer L.F. Lee, Dawn P. Richards, Daniel Pereira, Tania H. Watts, Mark S. Silverberg, Charles N. Bernstein, Diane Lacaille, Jenna Benoit, John Kim, Nadine Lalonde, Janet Gunderson, Hugues Allard-Chamard, Sophie Roux, Joshua Quan, Lindsay Hracs, Elizabeth Turnbull, Valeria Valerio, Sasha Bernatsky. DOI 10.3899/jrheum.2023-1214

SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice Communications Biology, 2024/02/16. Julian Daniel Sunday Willett, Annie Gravel, Isabelle Dubuc, Leslie Gudimard, Ana Claudia dos Santos Pereira Andrade, Émile Lacasse, Paul Fortin, Ju-Ling Liu, Jose Avila Cervantes, Jose Hector Galvez, Haig Hugo Vrej Djambazian, Melissa Zwaig, Anne-Marie Roy, Sally Lee, Shu-Huang Chen, Jiannis Ragoussis, Louis Flamand. DOI 10.1038/s42003-024-05878-3

Systemic Lupus Erythematosus Women with Lupus Nephritis in Pregnancy Therapeutic Challenge (SWITCH): The Systemic Lupus International Collaborating Clinics experience Annals of the Rheumatic Diseases, 2023/11. Joo-Young E Lee, Arielle Mendel, Anca Askanase, Sang-Cheol Bae, Jill P Buyon, Ann Elaine Clarke, Nathalie Costedoat-Chalumeau, Paul R Fortin, Dafna D Gladman, Rosalind Ramsey-Goldman, John G Hanly, Murat Inanç, David Alan Isenberg, Anselm Mak, Marta Mosca, Michelle Petri, Anisur Rahman, Jorge Sanchez-Guerrero, Murray Urowitz, Daniel J Wallace, Sasha Bernatsky, Évelyne Vinet. DOI 10.1136/ard-2023-224197

Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases The Journal of Rheumatology, 2023/07. Glen S. Hazlewood, Ines Colmegna, Carol Hitchon, Paul R. Fortin, Sasha Bernatsky, Ann E. Clarke, Dianne Mosher, Todd Wilson, Megan Thomas, Claire E.H. Barber, Mark Harrison, Nick Bansback, Laurie Proulx, Dawn P. Richards, Gilaad G. Kaplan. DOI 10.3899/jrheum.220697

Fluctuation of Anti–Domain 1 and Anti–β2‐Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies Arthritis & Rheumatology, 2023/06. Cecilia B. Chighizola, Francesca Pregnolato, Danieli Andrade, Maria Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza, H. Michael Belmont, Maria Gerosa, Paul Fortin, D. Ware Branch, Laura Andreoli, Michelle A. Petri, Ricard Cervera, Jason S. Knight, Rohan Willis, Maria Efthymiou, Hannah Cohen, Doruk Erkan, Maria Laura Bertolaccini. DOI 10.1002/art.42459

Evaluating the Construct of Damage in Systemic Lupus Erythematosus Arthritis Care & Research, 2023/05. Sindhu R. Johnson, Dafna D. Gladman, Hermine I. Brunner, David Isenberg, Ann E. Clarke, Megan R. W. Barber, Laurent Arnaud, Paul R. Fortin, Marta Mosca, Alexandre E. Voskuyl, Susan Manzi, Cynthia Aranow, Anca Askanase, Graciela S. Alarcón, Sang‐Cheol Bae, Nathalie Costedoat‐Chalumeau, Jessica A. English, Guillermo J. Pons‐Estel, Bernardo A. Pons‐Estel, Rebecca Gilman, Ellen M. Ginzler, John G. Hanly, Soren Jacobsen, Kenneth Kalunian, Diane L. Kamen, Chynace Lambalgen, Alexandra Legge, S. Sam Lim, Anselm Mak, Eric F. Morand, Christine A. Peschken, Michelle Petri, Anisur Rahman, Rosalind Ramsey‐Goldman, John A. Reynolds, Juanita Romero‐Diaz, Guillermo Ruiz‐Irastorza, Jorge Sanchez‐Guerrero, Elisabet Svenungsson, Zahi Touma, Murray Urowitz, Evelyne Vinet, Ronald F. van Vollenhoven, Heather Waldhauser, Daniel J. Wallace, Asad Zoma, Ian N. Bruce. DOI 10.1002/acr.24849

Measuring the Impact of MyLupusGuide in Canada: Results of a Randomized Controlled Study Arthritis Care & Research, 2023/03. Paul R. Fortin, Carolyn Neville, Anne‐Sophie Julien, Elham Rahme, Vinita Haroun, Jodie Nimigon‐Young, Anna‐Lisa Morrison, Davy Eng, Christine A. Peschken, Evelyne Vinet, Marie Hudson, Doug Smith, Mark Matsos, Janet E. Pope, Ann E. Clarke, Stephanie Keeling, J. Antonio Avina‐Zubieta, Murray Rochon, Deborah Da Costa. DOI 10.1002/acr.24871

SARS-CoV-2 evolution in the absence of selective immune pressures, results in antibody resistance, interferon suppression and phenotypic differences by lineage 2023/01/17. Julian Daniel Sunday Willett, Annie Gravel, Isabelle Dubuc, Leslie Gudimard, Ana Claudia dos Santos Pereira Andrade, Émile Lacasse, Paul Fortin, Ju-Ling Liu, Jose Avila Cervantes, Jose Hector Galvez, Haig Hugo Vrej Djambazian, Melissa Zwaig, Anne-Marie Roy, Sally Lee, Shu-Huang Chen, Jiannis Ragoussis, Louis Flamand. DOI 10.1101/2023.01.16.523994

The role of mitochondria in rheumatic diseases Nature Reviews Rheumatology, 2022/11. Yann L. C. Becker, Bhargavi Duvvuri, Paul R. Fortin, Christian Lood, Eric Boilard. DOI 10.1038/s41584-022-00834-z

Predictors of Unsuccessful Hydroxychloroquine Tapering and Discontinuation: Can We Personalize Decision‐Making in Systemic Lupus Erythematosus Treatment? Arthritis Care & Research, 2022/07. Celline C. Almeida‐Brasil, Christian A. Pineau, Evelyne Vinet, John G. Hanly, Christine A. Peschken, Ann E. Clarke, Paul R. Fortin, Michal Abrahamowicz, Sasha Bernatsky. DOI 10.1002/acr.24548

Challenges of Perceived Self‐Management in Lupus Arthritis Care & Research, 2022/07. Paul R. Fortin, Deborah Da Costa, Carolyn Neville, Anne‐Sophie Julien, Elham Rahme, Vinita Haroun, Wendy Singer, Jodie Nimigon‐Young, Anna‐Lisa Morrison, Davy Eng, Christine A. Peschken, Evelyne Vinet, Marie Hudson, Doug Smith, Mark Matsos, Janet E. Pope, Ann E. Clarke, Stephanie Keeling, J. Antonio Avina‐Zubieta, Murray Rochon. DOI 10.1002/acr.24542

Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus Lupus Science & Medicine, 2022/03. Stephan Hasse, Anne-Sophie Julien, Anne-Claire Duchez, Chenqi Zhao, Eric Boilard, Paul R Fortin, Sylvain G Bourgoin. DOI 10.1136/lupus-2021-000605

The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis The Journal of Immunology, 2022/03/01. Chakib Hamoudi, Chenqi Zhao, Amna Abderrazak, Mabrouka Salem, Paul R. Fortin, Jean Sévigny, Fawzi Aoudjit. DOI 10.4049/jimmunol.2100550

Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria Arthritis Care & Research, 2021/09. Michelle Petri, Daniel W. Goldman, Graciela S. Alarcón, Caroline Gordon, Joan T. Merrill, Paul R. Fortin, Ian N. Bruce, David Isenberg, Daniel Wallace, Ola Nived, Rosalind Ramsey‐Goldman, Sang‐Cheol Bae, John G. Hanly, Jorge Sanchez‐Guerrero, Ann E. Clarke, Cynthia Aranow, Susan Manzi, Murray Urowitz, Dafna D. Gladman, Ken Kalunian, Victoria P. Werth, Asad Zoma, Sasha Bernatsky, Munther Khamashta, Søren Jacobsen, Jill P. Buyon, Mary Anne Dooley, Ronald van Vollenhoven, Ellen Ginzler, Thomas Stoll, Christine Peschken, Joseph L. Jorizzo, Jeffery P. Callen, Sam Lim, Murat Inanç, Diane L. Kamen, Anisur Rahman, Kristjan Steinsson, Andrew G. Franks, Jr, Laurence S. Magder. DOI 10.1002/acr.24263

Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study Journal of Psychosomatic Research, 2021. Wu, Y., Kwakkenbos, L., Henry, R.S., Carrier, M.-E., Gagarine, M., Harb, S., Bourgeault, A., Tao, L., Carboni-Jiménez, A., Negeri, Z., Patten, S., Bartlett, S.J., Mouthon, L., Varga, J., Benedetti, A., Thombs, B.D., Fortuné, C., Gietzen, A., Guillot, G., Lewis, N., Richard, M., Sauvé, M., Welling, J., Fligelstone, K., Gottesman, K., Leite, C., Pérez, E., Baron, M., Malcarne, V., Mayes, M.D., Nielson, W.R., Riggs, R., Assassi, S., Ells, C., van den Ende, C., Frech, T., Harel, D., Hinchcliff, M., Hudson, M., Johnson, S.R., Larche, M., Nguyen, C., Pope, J., Rannou, F., Reyna, T.S.R., Schouffoer, A.A., Suarez-Almazor, M.E., Agard, C., Albert, A., Bernstein, E.J., Berthier, S., Bissonnette, L., Bruns, A., Carreira, P., Chaigne, B., Chung, L., Correia, C., Denton, C., Domsic, R., Dunne, J.V., Dunogue, B., Farge-Bancel, D., Fortin, P.R., Gordon, J., Granel-Rey, B., Hatron, P.-Y., Herrick, A.L., Hoa, S., Jones, N., Fernandes, A.J.D.B., Kafaja, S., Khalidi, N., Launay, D., Manning, J., Marie, I., Martin, M., Mekinian, A., Melchor, S., Nikpour, M., Olagne, L., Proudman, S., Régent, A., Rivière, S., Robinson, D., Rodriguez, E., Roux, S., Sobanski, V., Steen, V., Sutton, E., Thorne, C., Wilcox, P., Ayala, M.C., Nordlund, J., Østbø, N., Rice, D.B., Turner, K.A., Culos-Reed, N., Dyas, L., El-Baalbaki, G., Hebblethwaite, S., Bustamante, L., Duchek, D., Ellis, K.. DOI 10.1016/j.jpsychores.2020.110314

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus Journal of Autoimmunity, 2020. Enocsson, H., Wirestam, L., Dahle, C., Padyukov, L., Jönsen, A., Urowitz, M.B., Gladman, D.D., Romero-Diaz, J., Bae, S.-C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A.E., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Ginzler, E., Alarcón, G.S., Chatham, W.W., Petri, M., Khamashta, M., Aranow, C., Mackay, M., Dooley, M.A., Manzi, S., Ramsey-Goldman, R., Nived, O., Steinsson, K., Zoma, A.A., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., van Vollenhoven, R.F., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C.A., Askanase, A., Stoll, T., Bruce, I.N., Wetterö, J., Sjöwall, C.. DOI 10.1016/j.jaut.2019.102340

Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis Journal of Thrombosis and Haemostasis, 2020. Ortel, T.L., Meleth, S., Catellier, D., Crowther, M., Erkan, D., Fortin, P.R., Garcia, D., Haywood, N., Kosinski, A.S., Levine, S.R., Phillips, M.J., Whitehead, N.. DOI 10.1111/jth.14936

Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index Arthritis and Rheumatology, 2020. Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D.J., Bernatsky, S., Clarke, A.E., Merrill, J.T., Ginzler, E.M., Fortin, P.R., Gladman, D.D., Urowitz, M.B., Bruce, I.N., Isenberg, D.A., Rahman, A., Alarcón, G.S., Petri, M., Khamashta, M.A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Zoma, A.A., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S.S., Inanc, M., van Vollenhoven, R.F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D.L., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Askanase, A., Hanly, J.G.. DOI 10.1002/art.41144

Platelets disseminate extracellular vesicles in lymph in rheumatoid arthritis Arteriosclerosis, Thrombosis, and Vascular Biology, 2020. Tessandier, N., Melki, I., Cloutier, N., Allaeys, I., Miszta, A., Tan, S., Milasan, A., Michel, S., Benmoussa, A., Lévesque, T., Côté, F., McKenzie, S.E., Gilbert, C., Provost, P., Brisson, A.R., Wolberg, A.S., Fortin, P.R., Martel, C., Boilard, É.. DOI 10.1161/ATVBAHA.119.313698

Pilot study of anti-mitochondrial antibodies in antiphospholipid syndrome Lupus, 2020. Becker, Y.L.C., Julien, A.-S., Godbout, A., Boilard, É., Fortin, P.R.. DOI 10.1177/0961203320944481

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study Arthritis and Rheumatology, 2020. Hanly, J.G., Li, Q., Su, L., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E.M., Dooley, M.A., Steinsson, K., Ramsey-Goldman, R., Zoma, A.A., Manzi, S., Nived, O., Jonsen, A., Khamashta, M.A., Alarcón, G.S., Svenungsson, E., van Vollenhoven, R.F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Ramos-Casals, M., Lim, S.S., Inanc, M., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Askanase, A., Theriault, C., Farewell, V.. DOI 10.1002/art.41070

Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS) Arthritis Research and Therapy, 2020. Zheng, B., Hudson, M., Wang, M., Baron, M., Pope, J.E., Baron, M., Hudson, M., Gyger, G., Larché, M.J., Khalidi, N.A., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Maltez, N., Smith, D., Thorne, C., Ikic, A., Fortin, P.R., Fritzler, M.J.. DOI 10.1186/s13075-020-02220-0

IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species FASEB Journal, 2020. Huot, S., Laflamme, C., Fortin, P.R., Boilard, E., Pouliot, M.. DOI 10.1096/fj.202001085R

FcgRIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus Blood, 2020. Melki, I., Allaeys, I., Tessandier, N., Mailhot, B., Cloutier, N., Campbell, R.A., Rowley, J.W., Salem, D., Zufferey, A., Laroche, A., Lévesque, T., Patey, N., Rauch, J., Lood, C., Droit, A., McKenzie, S.E., Machlus, K.R., Rondina, M.T., Lacroix, S., Fortin, P.R., Boilard, E.. DOI 10.1182/blood.2020004974

Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach Arthritis Care and Research, 2020. Barber, M.R.W., Hanly, J.G., Su, L., Urowitz, M.B., St. Pierre, Y., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P.R., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Mackay, M., Alarcón, G.S., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Farewell, V., Stoll, T., Buyon, J., Clarke, A.E.. DOI 10.1002/acr.24092

Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map Patient, 2020. Toupin-April, K., Huber, A.M., Duffy, C.M., Proulx, L., Morgan, E.M., Cohen, J.S., Gaboury, I., Li, L.C., Tugwell, P., Stinson, J., Couchman, D., Berbatovci, F., Boyd, A., Sachs, H., Sirois, A., Sivakumar, A., Ragusa, M., El Hindi, T., Stringer, E., Cavallo, S., Ueffing, E., Gibbon, M., Fortin, P.R., Brinkman, W., Connelly, M., Weiss, J.E., Gmuca, S., Décary, S.. DOI 10.1007/s40271-020-00458-z

Construction of a frailty index as a novel health measure in systemic lupus erythematosus Journal of Rheumatology, 2020. Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D.J., Bernatsky, S., Clarke, A.E., Merrill, J.T., Ginzler, E.M., Fortin, P., Gladman, D.D., Urowitz, M.B., Bruce, I.N., Isenberg, D.A., Rahman, A., Alarcon, G.S., Petri, M., Khamashta, M.A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Zoma, A.A., Aranow, C., MacKay, M., Ruiz-Irastorza, G., Lim, S.S., Inanc, M., Van Vollenhoven, R.F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D.L., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Askanase, A., Hanly, J.G.. DOI 10.3899/jrheum.181338

Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry Lupus, 2020. Zuily, S., Clerc-Urmès, I., Bauman, C., Andrade, D., Sciascia, S., Pengo, V., Tektonidou, M.G., Ugarte, A., Gerosa, M., Michael Belmont, H., Zamorano, M.A.A., Fortin, P., Ji, L., Efthymiou, M., Cohen, H., Branch, D.W., Jesus, G.R.D., Nalli, C., Petri, M., Rodriguez, E., Cervera, R., Knight, J.S., Atsumi, T., Willis, R., Bertolaccini, M.L., Vega, J., Wahl, D., Erkan, D.. DOI 10.1177/0961203320940776

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort Arthritis and Rheumatology, 2020. Urowitz, M.B., Gladman, D.D., Farewell, V., Su, J., Romero-Diaz, J., Bae, S.-C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A.E., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Ginzler, E., Alarcón, G.S., Chatham, W.W., Petri, M.A., Bruce, I.N., Khamashta, M.A., Aranow, C., Dooley, M.A., Manzi, S., Ramsey-Goldman, R., Nived, O., Jönsen, A., Steinsson, K., Zoma, A.A., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Ỉnanç, M., van Vollenhoven, R., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C.A., Askanase, A., Stoll, T.. DOI 10.1002/art.41392

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen Rheumatology (United Kingdom), 2019. Mendel, A., Bernatsky, S., Pineau, C.A., St-Pierre, Y., Hanly, J.G., Urowitz, M.B., Clarke, A.E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Wallace, D.J., Merrill, J.T., Buyon, J., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Dooley, M.A., Fortin, P., Gladman, D.D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., MacKay, M., Alarcón, G., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, Sø., Askanase, A., Sanchez-Guerrero, J., Bruce, I.N., Costedoat-Chalumeau, N., Vinet, E.. DOI 10.1093/rheumatology/kez014

The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis Thrombosis Research, 2019. Sciascia, S., Willis, R., Pengo, V., Krilis, S., Andrade, D., Tektonidou, M.G., Ugarte, A., Chighizola, C., Branch, D.W., Levy, R.A., Nalli, C., Fortin, P.R., Petri, M., Rodriguez, E., Rodriguez-Pinto, I., Atsumi, T., Nascimento, I., Rosa, R., Banzato, A., Erkan, D., Cohen, H., Efthymiou, M., Mackie, I., Bertolaccini, M.L.. DOI 10.1016/j.thromres.2019.01.010

The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort Seminars in Arthritis and Rheumatism, 2019. Radin, M., Sciascia, S., Erkan, D., Pengo, V., Tektonidou, M.G., Ugarte, A., Meroni, P., Ji, L., Belmont, H.M., Cohen, H., Ramires de Jesús, G., Branch, D.W., Fortin, P.R., Andreoli, L., Petri, M., Rodriguez, E., Rodriguez-Pinto, I., Knight, J.S., Atsumi, T., Willis, R., Gonzalez, E., Lopez-Pedrera, R., Rossi Gandara, A.P., Borges Gualhardo Vendramini, M., Banzato, A., Sevim, E., Barbhaiya, M., Efthymiou, M., Mackie, I., Bertolaccini, M.L., Andrade, D.. DOI 10.1016/j.semarthrit.2019.04.009

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository Arthritis Care and Research, 2019. Unlu, O., Erkan, D., Barbhaiya, M., Andrade, D., Nascimento, I., Rosa, R., Banzato, A., Pengo, V., Ugarte, A., Gerosa, M., Ji, L., Efthymiou, M., Branch, D.W., de Jesus, G.R., Tincani, A., Belmont, H.M., Fortin, P.R., Petri, M., Rodriguez, E., Pons-Estel, G.J., Knight, J.S., Atsumi, T., Willis, R., Zuily, S., Tektonidou, M.G.. DOI 10.1002/acr.23584

Response to Middleton KR et als. Yoga and SLE Complementary Therapies in Medicine, 2019. Lee, J., Pineau, C.A., Da Costa, D., Clarke, A.E., Fortin, P.R., Neville, C., Neville, A., Bernatsky, S.. DOI 10.1016/j.ctim.2019.02.019

Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study Arthritis and Rheumatology, 2019. Hanly, J.G., Li, Q., Su, L., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E., Dooley, M.A., Steinsson, K., Ramsey-Goldman, R., Zoma, A.A., Manzi, S., Nived, O., Jonsen, A., Khamashta, M.A., Alarcón, G.S., van Vollenhoven, R.F., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Ramos-Casals, M., Lim, S.S., Inanc, M., Kalunian, K.C., Jacobsen, S., Peschken, C.A., Kamen, D.L., Askanase, A., Theriault, C., Farewell, V.. DOI 10.1002/art.40764

Persistent disease activity remains a burden for patients with systemic lupus erythematosus Journal of Rheumatology, 2019. Peschken, C.A., Wang, Y., Abrahamowicz, M., Pope, J., Silverman, E., Sayani, A., Iczkovitz, S., Ross, J., Zummer, M., Tucker, L., Pineau, C., Levy, D., Hudson, M., Hitchon, C.A., Huber, A.M., Smith, C.D., Avina-Zubieta, A., Arbillaga, H., Chédeville, G., Wynant, W., Fortin, P.R.. DOI 10.3899/jrheum.171454

Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort Journal of Rheumatology, 2019. Wirestam, L., Enocsson, H., Skogh, T., Padyukov, L., Jönsen, A., Urowitz, M.B., Gladman, D.D., Romero-DIaz, J., Bae, S.-C., Fortin, P.R., Sanchez-Guerrero, J., Clarke, A.E., Bernatsky, S., Gordon, C., Hanly, J.G., Wallace, D., Isenberg, D.A., Rahman, A., Merrill, J., Ginzler, E., Alarcón, G.S., Chatham, W.W., Petri, M., Khamashta, M., Aranow, C., MacKay, M., Dooley, M.A., Manzi, S., Ramsey-Goldman, R., Nived, O., Steinsson, K., Zoma, A., Ruiz-Irastorza, G., Lim, S., Kalunian, K., Inanc, M., Van Vollenhoven, R., Ramos-Casals, M., Kamen, D.L., Jacobsen, S., Peschken, C., Askanase, A., Stoll, T., Bruce, I.N., Wetterö, J., Sjöwall, C.. DOI 10.3899/jrheum.180713

Neuropsychiatric events in systemic lupus erythematosus: A longitudinal analysis of outcomes in an international inception cohort using a multistate model approach Annals of the Rheumatic Diseases, 2019. Hanly, J.G., Urowitz, M.B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sanchez-Guerrero, J., Bernatsky, S., Clarke, A.E., Wallace, D.J., Isenberg, D.A., Rahman, A., Merrill, J.T., Fortin, P.R., Gladman, D.D., Bruce, I.N., Petri, M., Ginzler, E.M., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Jönsen, A., Alarcón, G.S., Van Vollenhoven, R.F., Aranow, C., MacKay, M., Ruiz-Irastorza, G., Lim, S., Inanc, M., Kalunian, K.C., Jacobsen, Sø., Peschken, C.A., Kamen, D.L., Askanase, A., Farewell, V.. DOI 10.1136/annrheumdis-2019-216150

Mammalian target of rapamycin is activated in the kidneys of patients with scleroderma renal crisis Journal of Scleroderma and Related Disorders, 2019. Salituri, J., Patey, N., Takano, T., Fiset, P., Del Rincon, S., Berkson, L., Baron, M., Hudson, M., Baron, M., Hudson, M., Gyger, G., Pope, J., Larché, M., Khalidi, N., Masetto, A., Sutton, E., Robinson, D., Rodriguez-Reyna, T.S., Smith, D., Thorne, C., Fortin, P.R., Fritzler, M.. DOI 10.1177/2397198319885488

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort Annals of the Rheumatic Diseases, 2019. Mendel, A., Bernatsky, S.B., Hanly, J.G., Urowitz, M.B., Clarke, A.E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Wallace, D.J., Merrill, J.T., Buyon, J.P., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Dooley, M.A., Fortin, P.R., Gladman, D.D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Mackay, M., Alarcón, G.S., Manzi, S., Nived, O., Jönsen, A., Zoma, A.A., Van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, Sø., Askanase, A., Sanchez-Guerrero, J., Bruce, I.N., Costedoat-Chalumeau, N., Vinet, E.. DOI 10.1136/annrheumdis-2018-214434

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study BJOG: An International Journal of Obstetrics and Gynaecology, 2019. de Jesús, G.R., Sciascia, S., Andrade, D., Barbhaiya, M., Tektonidou, M., Banzato, A., Pengo, V., Ji, L., Meroni, P.L., Ugarte, A., Cohen, H., Branch, D.W., Andreoli, L., Belmont, H.M., Fortin, P.R., Petri, M., Rodriguez, E., Cervera, R., Knight, J.S., Atsumi, T., Willis, R., Nascimento, I.S., Rosa, R., Erkan, D., Levy, R.A.. DOI 10.1111/1471-0528.15469

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus Arthritis and Rheumatology, 2019. Legge, A., Kirkland, S., Rockwood, K., Andreou, P., Bae, S.-C., Gordon, C., Romero-Diaz, J., Sanchez-Guerrero, J., Wallace, D.J., Bernatsky, S., Clarke, A.E., Merrill, J., Ginzler, E.M., Fortin, P., Gladman, D.D., Urowitz, M.B., Bruce, I.N., Isenberg, D., Rahman, A., Alarcón, G.S., Petri, M., Khamashta, M.A., Dooley, M.A., Ramsey-Goldman, R., Manzi, S., Steinsson, K., Zoma, A.A., Aranow, C., Mackay, M., Ruiz-Irastorza, G., Lim, S.S., Inanc, M., van Vollenhoven, R.F., Jonsen, A., Nived, O., Ramos-Casals, M., Kamen, D.L., Kalunian, K., Jacobsen, S., Peschken, C.A., Askanase, A., Hanly, J.G.. DOI 10.1002/art.40859

Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice PLoS ONE, 2019. Cesaro, A., Defrêne, J., Lachhab, A., Pagé, N., Tardif, M.R., Al-Shami, A., Oravecz, T., Fortin, P.R., Daudelin, J.-F., Labrecque, N., Aoudjit, F., Pelletier, M., Tessier, P.A.. DOI 10.1371/journal.pone.0221528

Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository Journal of Thrombosis and Haemostasis, 2019. Efthymiou, M., Mackie, I.J., Lane, P.J., Andrade, D., Willis, R., Erkan, D., Sciascia, S., Krillis, S., Bison, E., Borges Galhardo Vendramini, M., Romay-Penabad, Z., Qi, M., Tektonidou, M., Ugarte, A., Chighizola, C., Belmont, H.M., Aguirre, M.A., Ji, L., Branch, D.W., de Jesus, G., Fortin, P.R., Andreoli, L., Petri, M., Cervera, R., Rodriguez, E., Knight, J.S., Atsumi, T., Vega, J., Sevim, E., Bertolaccini, M.L., Pengo, V., Cohen, H.. DOI 10.1111/jth.14596

Autoantibodies in systemic lupus erythematosus target mitochondrial RNA Frontiers in Immunology, 2019. Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P.R., Boilard, E.. DOI 10.3389/fimmu.2019.01026

Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort Arthritis Care and Research, 2019. Choi, M.Y., Clarke, A.E., St. Pierre, Y., Hanly, J.G., Urowitz, M.B., Romero-Diaz, J., Gordon, C., Bae, S.-C., Bernatsky, S., Wallace, D.J., Merrill, J.T., Isenberg, D.A., Rahman, A., Ginzler, E.M., Petri, M., Bruce, I.N., Dooley, M.A., Fortin, P.R., Gladman, D.D., Sanchez-Guerrero, J., Steinsson, K., Ramsey-Goldman, R., Khamashta, M.A., Aranow, C., Alarcón, G.S., Manzi, S., Nived, O., Zoma, A.A., van Vollenhoven, R.F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S.S., Kalunian, K.C., Inanc, M., Kamen, D.L., Peschken, C.A., Jacobsen, S., Askanase, A., Stoll, T., Buyon, J., Mahler, M., Fritzler, M.J.. DOI 10.1002/acr.23712

Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations Scientific Reports, 2019. Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., Eder, L., Wagner, É., Pelletier, M., Hajj, H.E., Tremblay, M.-È., Belleannée, C., Hébert, M.-J., Dieudé, M., Rauch, J., Fortin, P.R., Boilard, E.. DOI 10.1038/s41598-019-40900-3

A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort Rheumatology (United Kingdom), 2019. Kim, H., Levy, D.M., Silverman, E.D., Hitchon, C., Bernatsky, S., Pineau, C., Smith, C.D., Tucker, L., Petty, R., Arbillaga, H., Zummer, M., Hudson, M., Fortin, P., Huber, A.M., Chedeville, G., Peschken, C., Pope, J.E.. DOI 10.1093/rheumatology/kez006